Services

  1. Lyophilization / Late-Phase And Commercial Pharmaceutical Manufacturing 1/28/2014

    OsoBio is committed to serving as your contract manufacturing organization (CMO) of choice for late-phase clinical trials and bringing them to commercialization – especially those that involve biologic, highly potent or controlled compounds.

  2. Fill & Finish / Potent And Cytotoxic Compounds 1/28/2014

    As a first adopter of new international cross-containment guidelines recommended by ISPE (Risk-MaPP), OsoBio expertly manages the risks posed by potent and cytotoxic compounds and DEA scheduled substances, successfully balancing the need for product quality and operator safety.

  3. Lyophilization / Potent And Cytotoxic Compounds 1/28/2014

    As a first adopter of new international cross-containment guidelines recommended by ISPE (Risk-MaPP), OsoBio expertly manages the risks posed by potent and cytotoxic compounds and DEA scheduled substances, successfully balancing the need for product quality and operator safety.

  4. Fill & Finish / Clinical Trials Manufacturing 1/28/2014

    OsoBio offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category.

  5. Lyophilization / Clinical Trials Manufacturing 1/28/2014

    OsoBio offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category.

  6. Contract Development Services 1/13/2014

    Norwich offers comprehensive product development capabilities with R&D, GMP pilot scale manufacturing, analytical development and validation, and testing services. Our fully licensed facilities allow for quick and seamless transition from early stage development through clinical supplies and submission batch manufacturing.

  7. Contract Manufacturing Services 1/12/2014

    Norwich offers a full range of solid dose manufacturing and packaging capabilities with flexible containment solutions for potent compounds.

  8. Semi-Solid & Liquid Manufacturing 1/10/2014

    DPT’s Center of Excellence for Semi-solids and Liquids is supported by in-house quality and microbiology labs, robust quality systems and a team of highly skilled technicians to support your manufacturing needs.

  9. Clinical Trial Manufacturing 1/3/2014

    OsoBio offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category.

  10. Potent And Cytotoxic Compounds 1/3/2014

    As a first adopter of new international cross-containment guidelines recommended by ISPE (Risk-MaPP), OsoBio expertly manages the risks posed by potent and cytotoxic compounds and DEA scheduled substances, successfully balancing the need for product quality and operator safety.